Senator Investment Group LP Adaptive Biotechnologies Corp Transaction History

Senator Investment Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$7.8 - $10.11 $3.9 Million - $5.06 Million	-500,000 Reduced 50.0%	500,000 $4.42 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $9.32 Million - $16.9 Million	-250,000 Reduced 20.0%	1,000,000 $40.3 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $22.5 Million - $32.7 Million	-500,000 Reduced 28.57%	1,250,000 $73.9 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $3.58 Million - $4.88 Million	100,000 Added 6.06%	1,750,000 $85.1 Million
Q2 2020 Aug 13, 2020	SELL	$24.95 - $48.38 $43.4 Million - $84.1 Million	-1,738,085 Reduced 51.3%	1,650,000 $79.8 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $29.3 Million - $58.9 Million	-1,725,000 Reduced 33.74%	3,388,085 $94.1 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $206 Million - $247 Million	5,113,085 New	5,113,085 $210 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.